Guggenheim Maintains Buy on Bruker, Raises Price Target to $70
Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ: BRKR ) with a Buy and raises the price target from $50 to $70.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.